Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Kelly

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
Biochemical and Biophysical Research Communications|October 12, 2004
Cloning and characterization of the lanosterol 14alpha-demethylase (ERG11) gene in Cryptococcus neoformansS G Revankar, J Fu, M G Rinaldi, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1997
Itraconazole resistance in Aspergillus fumigatusD W Denning, K Venkateswarlu, K L Oakley, et al.
International Immunology|April 28, 2000
B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR alpha-chemokineM A Sleeman, J K Fraser, J G Murison, et al.
Journal of Dental Research|October 6, 2011
Triclosan antagonizes fluconazole activity against Candida albicansJ Higgins, E Pinjon, H N Oltean, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzymeA G S Warrilow, C M Hull, J E Parker, et al.
Bioresource Technology|August 31, 2010
Expression of bacterial levanase in yeast enables simultaneous saccharification and fermentation of grass juice to bioethanolC M Martel, J E Parker, C J Jackson, et al.
Antimicrobial Agents and Chemotherapy|July 30, 2008
CYP56 (Dit2p) in Candida albicans: characterization and investigation of its role in growth and antifungal drug susceptibilityN R Melo, G P Moran, A G S Warrilow, et al.
Bioresource Technology|February 16, 2010
Expression, purification and use of the soluble domain of Lactobacillus paracasei beta-fructosidase to optimise production of bioethanol from grass fructansC M Martel, A G S Warrilow, C J Jackson, et al.
Plos One|July 5, 2013
Discovery of a novel dual fungal CYP51/human 5-lipoxygenase inhibitor: implications for anti-fungal therapyEric K Hoobler, Ganesha Rai, Andrew G S Warrilow, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Biochemical and Biophysical Research Communications|October 12, 2004
Cloning and characterization of the lanosterol 14alpha-demethylase (ERG11) gene in Cryptococcus neoformansS G Revankar, J Fu, M G Rinaldi, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1997
Itraconazole resistance in Aspergillus fumigatusD W Denning, K Venkateswarlu, K L Oakley, et al.
International Immunology|April 28, 2000
B cell- and monocyte-activating chemokine (BMAC), a novel non-ELR alpha-chemokineM A Sleeman, J K Fraser, J G Murison, et al.
Journal of Dental Research|October 6, 2011
Triclosan antagonizes fluconazole activity against Candida albicansJ Higgins, E Pinjon, H N Oltean, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzymeA G S Warrilow, C M Hull, J E Parker, et al.
Bioresource Technology|August 31, 2010
Expression of bacterial levanase in yeast enables simultaneous saccharification and fermentation of grass juice to bioethanolC M Martel, J E Parker, C J Jackson, et al.
Antimicrobial Agents and Chemotherapy|July 30, 2008
CYP56 (Dit2p) in Candida albicans: characterization and investigation of its role in growth and antifungal drug susceptibilityN R Melo, G P Moran, A G S Warrilow, et al.
Bioresource Technology|February 16, 2010
Expression, purification and use of the soluble domain of Lactobacillus paracasei beta-fructosidase to optimise production of bioethanol from grass fructansC M Martel, A G S Warrilow, C J Jackson, et al.
Plos One|July 5, 2013
Discovery of a novel dual fungal CYP51/human 5-lipoxygenase inhibitor: implications for anti-fungal therapyEric K Hoobler, Ganesha Rai, Andrew G S Warrilow, et al.
Pageof 13